We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+11.59%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$676M
AUM Growth
+$13.1M
Cap. Flow
-$23.3M
Cap. Flow %
-3.45%
Top 10 Hldgs %
35.88%
Holding
700
New
222
Increased
104
Reduced
125
Closed
228

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$37.9M
2
MSFT icon
Microsoft
MSFT
+$36.5M
3
NVDA icon
NVIDIA
NVDA
+$29.1M
4
ALV icon
Autoliv
ALV
+$27.7M
5
TECK icon
Teck Resources
TECK
+$21.4M

Top Sells

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$121M
2
BABA icon
Alibaba
BABA
+$15.7M
3
MELI icon
Mercado Libre
MELI
+$14.3M
4
AMD icon
Advanced Micro Devices
AMD
+$13.1M
5
SE icon
Sea Limited
SE
+$13M

Sector Composition

Rank Sector Weight
1 Technology 33.65%
2 Consumer Discretionary 17.78%
3 Healthcare 10.68%
4 Financials 10.41%
5 Industrials 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRO icon
451
Sutro Biopharma
STRO
$428M
$99.3K 0.01%
2,135
-762
-26% -$37.9K
UAA icon
452
Under Armour
UAA
$2.45B
$99.3K 0.01%
13,747
-27,833
-67% -$224K
LOCO icon
453
El Pollo Loco
LOCO
$477M
$91.9K 0.01%
+10,480
New +$98.1K
ATRA icon
454
Atara Biotherapeutics
ATRA
$74.9M
$90.4K 0.01%
2,246
-1,973
-47% -$112K
PGEN icon
455
Precigen
PGEN
$2.57B
$89.6K 0.01%
77,955
FLWS icon
456
1-800-Flowers.com
FLWS
$255M
$89K 0.01%
+11,411
New +$105K
MTRX icon
457
Matrix Service
MTRX
$333M
$88.3K 0.01%
14,998
-1,200
-7% -$6.57K
NGM
458
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$83.8K 0.01%
32,352
-9,262
-22% -$33K
CMRX
459
DELISTED
Chimerix, Inc.
CMRX
$83.8K 0.01%
69,229
-101,606
-59% -$129K
CDXS icon
460
Codexis
CDXS
$163M
$81.5K 0.01%
29,121
LX
461
LexinFintech Holdings
LX
$237M
$80K 0.01%
34,939
-112,505
-76% -$273K
TG icon
462
Tredegar Corp
TG
$300M
$76.4K 0.01%
+11,456
New +$90.9K
HUYA
463
Huya Inc
HUYA
$556M
$76.2K 0.01%
21,279
NBP
464
NovaBridge Biosciences American Depositary Shares
NBP
$208M
$75.1K 0.01%
25,132
-28,661
-53% -$92.1K
MGNX icon
465
MacroGenics
MGNX
$257M
$74K 0.01%
13,838
-106,930
-89% -$660K
CCCC icon
466
C4 Therapeutics
CCCC
$406M
$73.5K 0.01%
26,721
-12,204
-31% -$39.2K
LU icon
467
Lufax Holding
LU
$1.47B
$63.3K 0.01%
11,075
-97,908
-90% -$647K
ZH
468
Zhihu
ZH
$284M
$60.7K 0.01%
+8,952
New +$58.8K
PBYI icon
469
Puma Biotechnology
PBYI
$449M
$57.4K 0.01%
16,247
-8,363
-34% -$26.1K
RYAM icon
470
Rayonier Advanced Materials
RYAM
$609M
$54.8K 0.01%
12,809
-22,489
-64% -$106K
VNET
471
VNET Group
VNET
$2.12B
$30.5K ﹤0.01%
10,517
-14,434
-58% -$43.9K
TDAY
472
USA Today Co
TDAY
$1.06B
$27.8K ﹤0.01%
12,358
-123,290
-91% -$246K
AA icon
473
Alcoa
AA
$13.6B
-71,813
Closed -$3.06M
AAL icon
474
American Airlines Group
AAL
$10.3B
-27,531
Closed -$406K
AAP icon
475
Advance Auto Parts
AAP
$3.37B
-1,740
Closed -$212K

Similar funds

Caxton Associates (New York)'s Q2 2023 Portfolio in Review

As of Q2 2023, Caxton Associates (New York) held 700 positions worth $676M, up 2% from $663M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Caxton Associates (New York) withdrew a net $23.3M in Q2 2023, closing 228 positions and reducing 125 holdings. Its most notable exit was Freeport-McMoran, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Caxton Associates (New York) opened a new position in Amazon worth $43.2M.

  • Caxton Associates (New York)'s largest Q2 2023 buy was Amazon: 331,495 shares worth $43.2M.
  • Caxton Associates (New York) added most to NVIDIA in Q2 2023, an estimated $29.1M increase.
  • Caxton Associates (New York)'s biggest Q2 2023 reduction was Alibaba, cutting an estimated $15.7M.
  • Caxton Associates (New York) fully exited Freeport-McMoran in Q2 2023, selling an estimated $121M.
  • Caxton Associates (New York)'s ten largest holdings make up 36% of its $676M portfolio in Q2 2023.
  • Caxton Associates (New York) opened 222 new positions and closed 228 in Q2 2023.
  • Caxton Associates (New York)'s portfolio value rose 2% quarter-over-quarter to $676M.

Based on Caxton Associates (New York)'s 13F filing for Q2 2023, filed 15 Aug 2023.